This National Coalition for LGBTQ Health on-demand webinar provides an in-depth look at current best practices on community responses to and education strategies regarding Mpox in the United States.
Join HealthHIV and Kathleen A. McManus, MD, MSCR, MSDC, FIDSA with the University of Virginia for an interactive webinar to discuss strategies for empowering providers to deliver affirming and comprehensive care for LGBTQ patients living with HIV.
During this webinar, presenters will discuss initial survey findings and implications from the Third Annual State of LGBTQ Health™ National Survey.
As there are rapid advancements in innovative HIV treatment, provider education must be timely and relevant to support providers to manage the complexity of patient care — from long-acting agents and injectables to new strategies for managing comorbidities and treatment resistance. Start your HIV innovation journey by enrolling in the free HealthHIV HIV Treatment Innovation™ Certificate Program that features leading experts in the field discussing the latest strategies in HIV treatment and management.
This webinar aims to highlight the work in protecting communities in the current mpox emergency and the evolving situation, including the specific needs of the different affected communities and how those can be addressed.
Dr. Demetre Daskalakis, CDC’s Director of the Division of HIV Prevention, delves into these clinical guidelines and reviews the latest PrEP science. Following his presentation, Dr. Anu Hazra will speak to the clinical considerations of the guidelines from a PrEP provider standpoint.
This interactive webinar featured the perspectives of multiple diverse HIV prevention experts on PrEP uptake among relevant consumer/patient communities, including Black women, same-gender-loving (SGL) Black and Latino men, and transgender individuals.
This timely webinar highlights the response of LGBTQ+ community groups and health centers as they support LGBTQ+ communities during this crisis.
This webinar will examine current regulatory and policy changes affecting LGBTQ patients’ out of pocket costs, and access to affordable medications and medically necessary care.